Reversible Visual Loss in a Patient Receiving High-dose Ciprofloxacin Hydrochloride (Cipro)

Tamara R. Vrabec; Robert C. Sergott; Edward A. Jaeger; Peter J. Savino; Thomas M. Bosley

doi:10.1016/S0161-6420(90)32518-6

Reversible Visual Loss in a Patient Receiving High-dose Ciprofloxacin Hydrochloride (Cipro)

Tamara R. Vrabec, Robert C. Sergott, Edward A. Jaeger, Peter J. Savino, Thomas M. Bosley

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Abstract

Bilateral acute visual loss characterized by cecocentral scotomas and acquired dyschromatopsia developed in a patient receiving large oral doses of ciprofloxacin hydrochloride (Cipro). The visual defects improved after cessation of this antibiotic. To our knowledge, this association has not been described previously. The use of this medication in high doses must be accompanied by careful monitoring of optic nerve function.

Original language	English (US)
Pages (from-to)	707-710
Number of pages	4
Journal	Ophthalmology
Volume	97
Issue number	6
DOIs	https://doi.org/10.1016/S0161-6420(90)32518-6
State	Published - Jan 1 1990
Externally published	Yes

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1016/S0161-6420(90)32518-6

Cite this

@article{4aee0c155cc84ddb8526e9e41b803ae7,

title = "Reversible Visual Loss in a Patient Receiving High-dose Ciprofloxacin Hydrochloride (Cipro)",

abstract = "Bilateral acute visual loss characterized by cecocentral scotomas and acquired dyschromatopsia developed in a patient receiving large oral doses of ciprofloxacin hydrochloride (Cipro). The visual defects improved after cessation of this antibiotic. To our knowledge, this association has not been described previously. The use of this medication in high doses must be accompanied by careful monitoring of optic nerve function.",

author = "Vrabec, {Tamara R.} and Sergott, {Robert C.} and Jaeger, {Edward A.} and Savino, {Peter J.} and Bosley, {Thomas M.}",

year = "1990",

month = jan,

day = "1",

doi = "10.1016/S0161-6420(90)32518-6",

language = "English (US)",

volume = "97",

pages = "707--710",

journal = "Ophthalmology",

issn = "0161-6420",

publisher = "Elsevier Inc.",

number = "6",

}

TY - JOUR

T1 - Reversible Visual Loss in a Patient Receiving High-dose Ciprofloxacin Hydrochloride (Cipro)

AU - Vrabec, Tamara R.

AU - Sergott, Robert C.

AU - Jaeger, Edward A.

AU - Savino, Peter J.

AU - Bosley, Thomas M.

PY - 1990/1/1

Y1 - 1990/1/1

N2 - Bilateral acute visual loss characterized by cecocentral scotomas and acquired dyschromatopsia developed in a patient receiving large oral doses of ciprofloxacin hydrochloride (Cipro). The visual defects improved after cessation of this antibiotic. To our knowledge, this association has not been described previously. The use of this medication in high doses must be accompanied by careful monitoring of optic nerve function.

AB - Bilateral acute visual loss characterized by cecocentral scotomas and acquired dyschromatopsia developed in a patient receiving large oral doses of ciprofloxacin hydrochloride (Cipro). The visual defects improved after cessation of this antibiotic. To our knowledge, this association has not been described previously. The use of this medication in high doses must be accompanied by careful monitoring of optic nerve function.

UR - http://www.scopus.com/inward/record.url?scp=0025372416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025372416&partnerID=8YFLogxK

U2 - 10.1016/S0161-6420(90)32518-6

DO - 10.1016/S0161-6420(90)32518-6

M3 - Article

C2 - 2374675

AN - SCOPUS:0025372416

SN - 0161-6420

VL - 97

SP - 707

EP - 710

JO - Ophthalmology

JF - Ophthalmology

IS - 6

ER -

Reversible Visual Loss in a Patient Receiving High-dose Ciprofloxacin Hydrochloride (Cipro)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this